Venmax Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE154G01022
  • NSEID:
  • BSEID: 531015
INR
12.20
-0.03 (-0.25%)
BSENSE

Nov 20

BSE+NSE Vol: 929

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 225982,
    "name": "Venmax Drugs",
    "stock_name": "Venmax Drugs",
    "full_name": "Venmax Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/venmax-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.20",
    "chg": -0.03,
    "chgp": "-0.25%",
    "dir": -1,
    "prev_price": "12.23",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531015,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE154G01022",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "929 ",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/venmax-drugs-225982-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.36 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1236-4264223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/VenmaxDrugsPhar_priceRelatedfactors_4264223.png",
        "date": "2026-11-16 14:35:12",
        "description": "A sharp decline of 17.71% in intraday trading dragged Venmax Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 12.36 on 16 Nov 2026, marking a significant underperformance against the broader market rally."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-valuation-shift-signals-price-attractiveness-change-4262862",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/VenmaxDrugsPhar_valuationdot_4262862.png",
        "date": "2026-11-16 08:00:17",
        "description": "Venmax Drugs & Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, coupled with its current financial metrics and market performance, suggests a cautious stance for investors amid a challenging industry backdrop."
      },
      {
        "title": "Venmax Drugs Gains 8.06%: Revenue Surge and Financial Turnaround Drive Weekly Move",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-gains-806-revenue-surge-and-financial-turnaround-drive-weekly-move-4262638",
        "imagepath": "",
        "date": "2026-11-15 13:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock rallies 5.40% on strong opening day</p>\n                    <p><strong>Nov 11:</strong> Stock dips 1.71% despite Sensex gains</p>\n                    <p><strong>Nov 12:</strong> Quarterly results reveal significant revenue growth</p>\n                    <p><strong>Nov 13:</strong> Stock rebounds 4.89% amid positive financial trend report</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.15.02</div><div class..."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Reports Positive Financial Trend Amidst Challenging Market Conditions",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-reports-positive-financial-trend-amidst-challenging-market-conditions-4259790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/VenmaxDrugsPhar_fintrenddot_4259790.png",
        "date": "2026-11-13 08:00:10",
        "description": "Venmax Drugs & Pharmaceuticals Ltd has demonstrated a notable improvement in its financial performance for the quarter ended September 2026, marking a shift from a previously flat trend to a positive trajectory. Despite lingering challenges reflected in its micro-cap status and a strong sell mojo grade, the company’s recent quarterly results reveal encouraging signs of growth and operational efficiency within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.75 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-of-rs1275-4196539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VenmaxDrugsPhar_priceRelatedfactors_4196539.png",
        "date": "2026-09-17 14:35:06",
        "description": "For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 12.75 on 17 Sep 2026. This marks a significant 44.28% drop over the past year, considerably underperforming the Sensex, which itself is down 10.02% over the same period."
      },
      {
        "title": "Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amidst Prolonged Downtrend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/venmax-drugs-pharmaceuticals-ltd-falls-to-52-week-low-amidst-continued-downtrend-4179883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VenmaxDrugsPhar_priceRelatedfactors_4179883.png",
        "date": "2026-09-02 14:35:10",
        "description": "For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has declined, culminating in a fresh 52-week low on 2 Sep 2026, as the stock slipped 7.06%% intraday. This latest drop extends a year-long slide where the share price has halved, contrasting sharply with the broader market's more modest losses."
      }
    ],
    "total": 21,
    "sid": "225982",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/venmax-drugs-pharmaceuticals-225982"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2026",
      "details": "News paper Publication of the Unaudited Financial Results for the Quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026.",
      "datetime": "12-Nov-2026",
      "details": "Unaudited Financial Results for the Quarter and Half Year ended September 30 206.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation & Variation",
      "datetime": "12-Nov-2026",
      "details": "Statement of Deviation and Variation for the Quarter ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2026 | Source : BSE

News paper Publication of the Unaudited Financial Results for the Quarter ended September 30 2026.

Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026.

12-Nov-2026 | Source : BSE

Unaudited Financial Results for the Quarter and Half Year ended September 30 206.

Statement Of Deviation & Variation

12-Nov-2026 | Source : BSE

Statement of Deviation and Variation for the Quarter ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available